Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Acta Trop ; 204: 105363, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32035055

ABSTRACT

Female Genital Schistosomiasis (FGS) is a neglected disease affecting millions, however challenging to diagnose. This explorative descriptive study compares Schistosoma real-time PCR analysis of cervico-vaginal lavages (CVL) with corresponding urine and stool samples of 933 women from five different previously described study populations. Sampling included 310 women from an S. mansoni endemic region in Mwanza, Tanzania and 112 women from a nearby S. haematobium endemic region. Findings were compared with samples collected from S. haematobium endemic regions in South Africa from 394 women and from 117 women from Madagascar of which 79 were urine pre-selected microscopy positive cases from highly-endemic communities and 38 were urine microscopy negatives from a low-endemic community. As anticipated, urine and stool microscopy and gynecological investigations varied substantially between study populations; however, the same Schistosoma real-time PCR was performed in one reference laboratory. Schistosoma DNA was detected in 13% (120/933) of the CVL, ranging from 3% in the S. mansoni Tanzanian endemic region to 61% in the pre-selected Malagasy urine microscopy positive cases. Detectable Schistosoma DNA in CVL was associated with Schistosoma DNA in urine but not with microscopic detection of eggs in urine or by cytological examination. This study confirmed real-time PCR for the detection of Schistosoma DNA in gynecological samples to be a valuable diagnostic tool to study the distribution of FGS within schistosomiasis endemic areas.


Subject(s)
Schistosoma haematobium/genetics , Schistosoma mansoni/genetics , Schistosomiasis haematobia/epidemiology , Schistosomiasis mansoni/epidemiology , Adolescent , Animals , Child , DNA, Helminth , Diagnostic Tests, Routine , Female , Genitalia/parasitology , Humans , Madagascar/epidemiology , Real-Time Polymerase Chain Reaction , Schistosomiasis haematobia/parasitology , Schistosomiasis mansoni/parasitology , South Africa/epidemiology , Tanzania/epidemiology , Urinalysis , Young Adult
2.
Nutr Diabetes ; 7(10): e289, 2017 Oct 16.
Article in English | MEDLINE | ID: mdl-29035384

ABSTRACT

Emerging evidence suggests that helminths might confer protection against the development of type 2 diabetes. We aimed to assess the role of adipokines in mediating the effect of helminths on insulin resistance. Serum samples were obtained from a randomized-controlled trial of anthelmintic treatment in an area endemic for soil-transmitted helminths (STH), Flores Island, Indonesia. In STH-infected subjects, anthelmintic treatment significantly increased the ratio of leptin to adiponectin (treatment effect factor (95% confidence interval (CI)), P-value for interaction: 1.20 (1.06-1.35), P=0.010), which largely stemmed from a significant reduction in adiponectin (0.91 (0.85-0.98), P=0.020) and a trend for an increase in leptin level (1.10 (1.00-1.21), P=0.119). No significant effect on resistin level was observed. This increase in leptin to adiponectin ratio seemed to contribute to the observed effect of deworming on increased insulin resistance (IR) as adjustment for leptin to adiponectin ratio attenuated the effect on IR from 1.07 (1.01-1.14, P=0.023) to 1.05 (0.99-1.11, P=0.075). Anthelmintic treatment in STH-infected subjects increases leptin to adiponectin ratio which may in small part contribute to the modest increase in IR. Further studies will be needed to assess the effect of the changes in adipokine levels on the host immune response and metabolism.


Subject(s)
Adiponectin/blood , Anthelmintics/administration & dosage , Leptin/blood , Adult , Albendazole/administration & dosage , Anthelmintics/adverse effects , Diabetes Mellitus, Type 2/immunology , Diabetes Mellitus, Type 2/parasitology , Double-Blind Method , Female , Helminthiasis/blood , Helminthiasis/drug therapy , Helminthiasis/immunology , Humans , Indonesia , Insulin Resistance , Male , Middle Aged , Placebos
4.
Ann Trop Med Parasitol ; 98(4): 385-90, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15228719

ABSTRACT

In November-December 2002, stool samples from a random sample of the human population (N = 190) in the Garu area of northern Ghana were checked for intestinal helminths, using a single Kato smear and duplicate coprocultures for each subject. All 190 subjects were subsequently treated with a single, 400-mg dose of albendazole and 146 of them were successfully re-examined 21-28 days post-treatment. Prior to treatment, 75.5% of the Kato smears were found to contain 'hookworm-like' eggs (with a geometric mean egg count among the positives of 578 eggs/g faeces), and the third-stage larvae of Oesophagostomum bifurcum and hookworm were found in the cultures of stools from 34.2% and 77.4% of the subjects, respectively. Among the subjects who had positive Kato smears before treatment, albendazole treatment led to a cure 'rate' of 79.0% and an egg-reduction 'rate' of 73.5%. The results from the coprocultures indicated cure 'rates' of 98.0% for O. bifurcum but only 51.3% for hookworm. Only one subject was still positive for O. bifurcum after treatment. Among those still positive for hookworm after treatment, the larva-reduction 'rate' was 79.8%. The egg-/larva-reduction 'rates' among those with heavy infections prior to treatment were >90%, whether the data analysed came from the Kato smears or the coprocultures. It may be concluded that a single dose of albendazole is very likely to cure an O. bifurcum infection and to reduce greatly the intensity (but not the prevalence) of any hookworm infections.


Subject(s)
Albendazole/therapeutic use , Anthelmintics/therapeutic use , Endemic Diseases , Hookworm Infections/drug therapy , Oesophagostomiasis/drug therapy , Animals , Ghana/epidemiology , Hookworm Infections/epidemiology , Humans , Oesophagostomiasis/epidemiology , Oesophagostomum/isolation & purification , Time Factors , Treatment Outcome
6.
Eur J Clin Microbiol Infect Dis ; 19(5): 358-61, 2000 May.
Article in English | MEDLINE | ID: mdl-10898137

ABSTRACT

Since Entamoeba histolytica and Entamoeba dispar were formally recognized as two different species at the World Health Organization (WHO)/Pan American Health Organization (PAHO)/United Nations Educational, Scientific and Cultural Organization (UNESCO) meeting in Mexico City in 1997, the specific differentiation of the two morphologically identical species would seem relevant in clinical diagnosis. Several polymerase chain reaction (PCR)-based methods have been described and used successfully, but methods for DNA isolation from cysts in stool samples are time-consuming and problematic due to inhibitory factors in faeces. The use of the slightly modified QIAamp tissue method (Qiagen, Germany) for DNA isolation was evaluated in 657 unpreserved faecal samples from cases of suspected Entamoeba histolytica/Entamoeba dispar infection. In only 1.7% of the cases was PCR hampered by inhibitors present in the faeces. The DNA isolation procedure was found to be rapid, simple and one that could easily be implemented in a routine diagnostic setting. In 98.8% of Entamoeba histolytica/Entamoeba dispar cyst-positive faecal samples, the true identity of the cysts could be determined using PCR specific for Entamoeba histolytica and Entamoeba dispar, respectively.


Subject(s)
DNA, Protozoan/isolation & purification , Entamoeba histolytica/classification , Entamoeba/classification , Entamoebiasis/parasitology , Feces/parasitology , Polymerase Chain Reaction/methods , Animals , DNA, Protozoan/analysis , Entamoeba/genetics , Entamoeba/growth & development , Entamoeba/isolation & purification , Entamoeba histolytica/genetics , Entamoeba histolytica/growth & development , Entamoeba histolytica/isolation & purification , Entamoebiasis/diagnosis , Humans , Immunoenzyme Techniques , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...